SEC Form D private-offering filing

Addition Therapeutics, Inc.

Name: Addition Therapeutics, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2025-12-22

A new SEC Form D private-offering notice from South San Francisco, CA, a $28,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Addition Therapeutics, Inc. site↗ Verified via SEC Form D

Genetic medicine company developing an all RNA, LNP based gene insertion platform (PRINT) for durable, one time therapies in obesity, Fabry disease, HIV, and ocular disease

Filed 2025-12-22Filed to raise $28,000,000First money in 2025-12-11Raised so far $28,000,000HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified additiontx.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.